These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


144 related items for PubMed ID: 22230866

  • 1. Nosocomial outbreak of carbapenem-resistant Pseudomonas aeruginosa carrying blaVIM-2 in burn wards, China.
    Zhang R, Mingcheng L, Dong X, Li F.
    Braz J Infect Dis; 2011; 15(5):505-6. PubMed ID: 22230866
    [No Abstract] [Full Text] [Related]

  • 2. Determination of extended spectrum beta-lactamases, metallo-beta-lactamases and AmpC-beta-lactamases among carbapenem resistant Pseudomonas aeruginosa isolated from burn patients.
    Neyestanaki DK, Mirsalehian A, Rezagholizadeh F, Jabalameli F, Taherikalani M, Emaneini M.
    Burns; 2014 Dec; 40(8):1556-61. PubMed ID: 24767143
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Molecular methods require for confirmation in bla AIM (Adelaide imipenemase) producing Pseudomonas aeruginosa.
    Banerjee P, Singh G.
    Burns; 2014 Nov; 40(7):1419. PubMed ID: 24969111
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Molecular characterization of multidrug-resistant (MDR) Pseudomonas aeruginosa isolated in a burn center.
    de Almeida Silva KCF, Calomino MA, Deutsch G, de Castilho SR, de Paula GR, Esper LMR, Teixeira LA.
    Burns; 2017 Feb; 43(1):137-143. PubMed ID: 27595453
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. First nosocomial outbreak of Pseudomonas aeruginosa producing an integron-borne metallo-beta-lactamase (VIM-2) in the United States.
    Lolans K, Queenan AM, Bush K, Sahud A, Quinn JP.
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3538-40. PubMed ID: 16048978
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Carbapenem-resistant Pseudomonas aeruginosa: association with virulence genes and biofilm formation.
    Rossi Gonçalves I, Dantas RCC, Ferreira ML, Batistão DWDF, Gontijo-Filho PP, Ribas RM.
    Braz J Microbiol; 2017 Aug; 48(2):211-217. PubMed ID: 28034598
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Beta-lactam resistance mechanisms in Pseudomonas aeruginosa strains causing bloodstream infections: comparative results between Brazilian and American isolates.
    Fehlberg LC, Xavier DE, Peraro PP, Marra AR, Edmond MB, Gales AC.
    Microb Drug Resist; 2012 Aug; 18(4):402-7. PubMed ID: 22455540
    [Abstract] [Full Text] [Related]

  • 16. Variability of the bla(IMP-15)-containing integrons, highly related to In95, on an endemic clone of Pseudomonas aeruginosa in Mexico.
    Garza-Ramos JU, Sanchez-Martinez G, Barajas JM, Suarez S, Sanchez-Perez A, Rojas-Moreno T, Carrillo-Quiroz B, Silva-Sanchez J.
    Microb Drug Resist; 2010 Sep; 16(3):191-5. PubMed ID: 20617927
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Emergence and dissemination of BEL-1-producing Pseudomonas aeruginosa isolates in Belgium.
    Bogaerts P, Bauraing C, Deplano A, Glupczynski Y.
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1584-5. PubMed ID: 17261629
    [No Abstract] [Full Text] [Related]

  • 19. Hospital outbreak of Pseudomonas aeruginosa producing extended-spectrum oxacillinase OXA-19.
    Cholley P, Hocquet D, Alauzet C, Cravoisy-Popovic A, Talon D, Aissa N, Plésiat P, Bertrand X.
    J Med Microbiol; 2010 Jul; 59(Pt 7):866-869. PubMed ID: 20299501
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.